All stock lists
Unlock the score
Evogene Ltd. (NASDAQ:EVGN)
Israel · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.37+0.00 (+1.35%)
Insider Score
/ 100
EVGN Insider Score
Evogene Ltd. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
EVGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 347.00 K | 334.00 K | 314.00 K | 312.00 K | 884.00 K | 2.44 M |
| Revenue Growth (YoY) | -60.75 % | -86.33 % | -80.51 % | -82.07 % | 46.12 % | -41.67 % |
| Cost of Revenue | 355.00 K | 130.00 K | 2.28 M | 157.00 K | 136.00 K | 1.61 M |
| Gross Profit | -8.00 K | 204.00 K | -1.97 M | 155.00 K | 748.00 K | 830.00 K |
| SG&A Expense | 1.21 M | 1.54 M | 1.20 M | 1.50 M | 1.50 M | 1.94 M |
| R&D Expense | 1.23 M | 1.84 M | 1.83 M | 1.38 M | 2.32 M | 3.21 M |
| Operating Expenses | 2.43 M | 3.35 M | 3.24 M | 2.88 M | 3.82 M | 4.96 M |
| Operating Income | -2.44 M | -3.15 M | -5.21 M | -2.72 M | -3.07 M | -4.13 M |
| Pretax Income | -1.59 M | -5.91 M | -5.34 M | -2.73 M | -3.53 M | -2.99 M |
| Tax Provision | 0.00 | 4.00 K | 0.00 | 1.00 K | 1.00 K | 0.00 |
| Net Income | -1.77 M | -5.87 M | -5.31 M | 3.87 M | -4.46 M | -2.59 M |
| EPS (Basic) | -0.14 | -0.60 | -0.61 | 0.44 | -0.62 | -0.38 |
| EPS (Diluted) | -0.14 | -0.60 | -0.61 | 0.44 | -0.62 | -0.38 |
| Shares Outstanding | 12.20 M | 9.74 M | 8.72 M | 8.72 M | 7.23 M | 6.80 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.